Want to see SE:LCLEAN full AI Analyst Report?
LCLEAN Stock Chart & Stats
kr0.09
-kr0.03(-7.18%)
At close: 4:00 PM EST
kr0.09
-kr0.03(-7.18%)
Day’s Range― - ―
52-Week Rangekr0.02 - kr0.38
Previous CloseN/A
Volume13.75K
Average Volume (3M)474.43K
Market Cap
kr33.23M
Enterprise Valuekr26.92M
Total Cash (Recent Filing)kr25.64M
Total Debt (Recent Filing)kr12.31M
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding1,025,575,800
10 Day Avg. Volume395,019
30 Day Avg. Volume474,432
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)kr135.00M
Bulls Say, Bears Say
Bulls Say
Structural Market DemandLifeClean serves infection control in healthcare and professional settings, a secular market with recurring hygiene needs and regulatory emphasis. This creates steady long-term addressable demand for disinfection products and services, supporting revenue durability if product-market fit and contracts persist.
Proprietary Product DifferentiationProprietary disinfection chemistry and bundled implementation services create differentiation and customer stickiness. A differentiated core technology can sustain margins, limit low-cost substitution, and enable recurring service or consumable revenue over months to years if efficacy and regulatory acceptance remain intact.
Balance-sheet RepairRecent rebuilding of equity and lower total debt reduces immediate solvency pressure and improves financing optionality. This structural repair, if maintained, lowers default and covenant risk, giving management room to stabilize operations, pursue sales investments, or negotiate better financing terms over coming quarters.
Bears Say
Chronic Negative Cash GenerationConsistent negative operating and free cash flows indicate the business cannot self-fund operations or growth. Over a multi-month horizon this forces reliance on external financing or equity raises, creating dilution risk and constraining investment in sales, R&D, or scaling necessary to reach sustainable profitability.
Deteriorating Revenue And Gross ProfitabilityDeclining revenue coupled with sharply negative gross profit signals weakening demand or margin compression from costs or pricing pressure. This undermines operating leverage and makes it harder to reverse losses; absent a clear improvement in top-line trends, profitability recovery is structurally more difficult.
Stressed Capital StructureHistorically extreme leverage and an episode of negative equity indicate limited financial resilience. Even with recent repair, the capital structure remains stressed versus peers, increasing cost of capital, raising refinancing and covenant risk, and limiting strategic flexibility over the medium term.
LifeClean International AB News
LCLEAN FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was kr0.02 and its highest was kr0.38 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is kr33.23M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Oct 23, 2026 which is in 93 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Jul 09, 2026. The company reported -kr0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.005.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of -kr0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in SE:LCLEAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.